Industry: Biomedicine Region: Poland Transaction Price: USD 1 million Transaction Method: Equity Financing
Project Description
The Polish company is seeking the following medicines:
1. Liquid dihydrofenac
demand product
Diffenac (liquid, drops, suspension, etc.) for oral use.
Purchase volume (approximately, per year)
872,000 bales
Sales Market
Sales in Europe, Middle East and Africa.
2. Gynecological products
demand product
●Probiotics
●Nifuratel + Nystatin
●Clindamycin
●Natamycin
●hydrocortisone + natamycin + neomycin (or other drugs with similar spectrum)
●Other drugs registered for gynecological indications
Purchase volume (approximately, next year)
Around 450K-550K packs, depending on the product.
Sales Market
Some products are sold in the Polish market, but most will be exported to EMEA countries.
Cooperation intention
Interested and qualified companies please contact us.